NCT03619993 Patient Preference for Pegfilgrastim (Neulasta®) Application Forms Status COMPLETED Phase NA
NCT03619187 An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients Status WITHDRAWN Phase PHASE3
NCT03608657 Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE) Status COMPLETED Phase N/A
NCT03600883 A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) Status COMPLETED Phase PHASE1/PHASE2
NCT03597009 A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion Status TERMINATED Phase PHASE1/PHASE2
NCT03584711 FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation Status COMPLETED Phase PHASE2
NCT03571828 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma Status TERMINATED Phase PHASE1
NCT03571633 Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03570697 Imaging of Coronary Plaques in Participants Treated With Evolocumab Status COMPLETED Phase PHASE3
NCT03554044 T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer Status COMPLETED Phase PHASE1
NCT03541369 Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT03539419 Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain Status COMPLETED Phase N/A
NCT03532087 Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT03520231 Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases Status COMPLETED Phase PHASE2
NCT03512353 A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers Status TERMINATED Phase PHASE2
NCT03500445 Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2